JP2005515964A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005515964A5 JP2005515964A5 JP2003508362A JP2003508362A JP2005515964A5 JP 2005515964 A5 JP2005515964 A5 JP 2005515964A5 JP 2003508362 A JP2003508362 A JP 2003508362A JP 2003508362 A JP2003508362 A JP 2003508362A JP 2005515964 A5 JP2005515964 A5 JP 2005515964A5
- Authority
- JP
- Japan
- Prior art keywords
- enantiomer
- prodrug
- isomer
- salt
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000651 prodrug Substances 0.000 claims 12
- 229940002612 prodrugs Drugs 0.000 claims 12
- 150000003839 salts Chemical class 0.000 claims 12
- 239000011780 sodium chloride Substances 0.000 claims 12
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims 8
- 229960005309 Estradiol Drugs 0.000 claims 8
- GCKMFJBGXUYNAG-HLXURNFRSA-N Methyltestosterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)CC2 GCKMFJBGXUYNAG-HLXURNFRSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- 229960001566 methyltestosterone Drugs 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 238000009472 formulation Methods 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 2
- 229920001888 polyacrylic acid Polymers 0.000 claims 2
- 239000004584 polyacrylic acid Substances 0.000 claims 2
- 239000002562 thickening agent Substances 0.000 claims 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000009245 menopause Effects 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Claims (12)
- それを必要とする雌性哺乳動物、好ましくはヒトにおいて、更年期障害が進行する危険性を治療し、予防し又は軽減させる組み合わせ医薬を製造するためのメチルテストステロン及び少なくとも1つの医薬的に許容可能なステロイドの使用であって、該組み合わせ医薬は:約0.2mg〜約50.0mgのメチルテストステロン又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩を経口投与量単位による投与のために;約0.1g〜約100.0mgのエストラジオール又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩を非経口投与量単位による投与のために含む、前記使用。
- メチルテストステロンを、錠剤、カプセル、カシェ剤、トローチ剤、調合散剤、顆粒剤、液剤、懸濁剤、エマルジョン又はリキッドの形態で投与する、請求項1に記載の使用。
- エストラジオール又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩を経皮投与する、請求項1に記載の使用。
- エストラジオール又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩を水性アルコールジェルの形態で投与する、請求項3に記載の使用。
- 水性アルコールジェルが、低級アルコール及び増粘剤のうちの少なくとも1つを更に含む、請求項4に記載の使用。
- 低級アルコールが、エタノール、2−プロパノール及びそれらの混合物から成る群より選択される、請求項5に記載の使用。
- 増粘剤がポリアクリル酸である、請求項5に記載の使用。
- エストラジオール又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩が経皮ジェル製剤として投与され、該製剤が、製剤の重量に対して:
(a) 約0.06〜約10.0重量%のエストラジオール又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩;
(b) 約0.1〜約5.0重量%のポリアクリル酸;
(c) 約0.1〜約5.0重量%のトリエタノールアミン;
(d) 約30.0〜約98.0重量%のエタノール;及び
(e) 製剤を100重量%にするのに十分な量の水、
を含む、請求項1に記載の使用。 - メチルテストステロン又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩及びエストラジオール又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩をキットの別成分としてそれぞれ提供する、請求項1に記載の使用。
- 哺乳動物がヒトである、請求項1に記載の使用。
- メチルテストステロン又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩及びエストラジオール又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩を連続的に投与する、請求項1に記載の使用。
- メチルテストステロン又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩及びエストラジオール又はそのエナンチオマー、アイソマー、プロドラッグ若しくは塩を実質的に同時に投与する、請求項1に記載の使用。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/892,981 US20030027804A1 (en) | 2001-06-27 | 2001-06-27 | Therapeutic combinations for the treatment of hormone deficiencies |
PCT/US2002/020141 WO2003002123A2 (en) | 2001-06-27 | 2002-06-26 | Therapeutic combinations for the treatment of hormone deficiencies |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005515964A JP2005515964A (ja) | 2005-06-02 |
JP2005515964A5 true JP2005515964A5 (ja) | 2006-01-05 |
Family
ID=25400826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003508362A Pending JP2005515964A (ja) | 2001-06-27 | 2002-06-26 | ホルモン欠乏症を治療するための治療用組成物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20030027804A1 (ja) |
EP (1) | EP1404343A4 (ja) |
JP (1) | JP2005515964A (ja) |
CA (1) | CA2451725C (ja) |
WO (1) | WO2003002123A2 (ja) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20040002482A1 (en) * | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
US20030139384A1 (en) * | 2000-08-30 | 2003-07-24 | Dudley Robert E. | Method for treating erectile dysfunction and increasing libido in men |
US20040072810A1 (en) * | 2001-11-07 | 2004-04-15 | Besins International Belgique | Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
IL163981A0 (en) * | 2002-03-15 | 2005-12-18 | Unimed Pharmaceuticals Inc | Androgen pharmaceutical composition and method fortreating depression |
MY139721A (en) | 2002-04-19 | 2009-10-30 | Cpex Pharmaceuticals Inc | Pharmaceutical composition |
US20040259852A1 (en) * | 2003-06-18 | 2004-12-23 | White Hillary D. | Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome |
US8883769B2 (en) * | 2003-06-18 | 2014-11-11 | White Mountain Pharma, Inc. | Methods for the treatment of fibromyalgia and chronic fatigue syndrome |
US20050037040A1 (en) * | 2003-08-13 | 2005-02-17 | Moshe Arkin | Topical compositions of urea and ammonium lactate |
US20050042182A1 (en) * | 2003-08-13 | 2005-02-24 | Moshe Arkin | Topical compositions of urea |
US20050036953A1 (en) * | 2003-08-13 | 2005-02-17 | Moshe Arkin | Topical compositions of ammonium lactate |
US20050020552A1 (en) * | 2003-07-16 | 2005-01-27 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
US20050025833A1 (en) * | 2003-07-16 | 2005-02-03 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
US20050042268A1 (en) * | 2003-07-16 | 2005-02-24 | Chaim Aschkenasy | Pharmaceutical composition and method for transdermal drug delivery |
US20050222106A1 (en) * | 2004-04-01 | 2005-10-06 | Stefan Bracht | Drospirenone-containing preparations for transdermal use |
PT1750766E (pt) | 2004-05-11 | 2013-09-30 | Emotional Brain Bv | Formulações farmacêuticas e suas utilizações no tratamento de disfunção sexual feminina |
KR20070073964A (ko) * | 2004-11-01 | 2007-07-10 | 앙도르쉐르슈 인코포레이티드 | 피부 노화 치료용 또는 피부 노화의 획득 가능성감소용으로서의 안드로겐의 용도 |
US20070088012A1 (en) * | 2005-04-08 | 2007-04-19 | Woun Seo | Method of treating or preventing type-2 diabetes |
US20070154533A1 (en) * | 2005-04-13 | 2007-07-05 | Dudley Robert E | Method of increasing testosterone and related steriod concentrations in women |
US20070065494A1 (en) * | 2005-08-03 | 2007-03-22 | Watson Laboratories, Inc. | Formulations and Methods for Enhancing the Transdermal Penetration of a Drug |
RS52671B (en) | 2005-10-12 | 2013-06-28 | Unimed Pharmaceuticals Llc | IMPROVED TESTOSTERON GEL AND USE PROCEDURE |
EP1790343A1 (en) | 2005-11-11 | 2007-05-30 | Emotional Brain B.V. | Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction |
US20070254036A1 (en) * | 2006-04-13 | 2007-11-01 | Besins Healthcare Sa | Treatment of menopause associated symptoms |
EP1925307A1 (en) | 2006-11-03 | 2008-05-28 | Emotional Brain B.V. | Use of 3-alpha-androstanediol in the treatment of sexual dysfunction |
EP2044943A1 (en) * | 2007-10-04 | 2009-04-08 | Solvay Pharmaceuticals, Inc. | Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using the same |
US20090285893A1 (en) * | 2008-05-19 | 2009-11-19 | The Procter & Gamble Company | Treatment of heart failure in women |
GB2482868A (en) * | 2010-08-16 | 2012-02-22 | Franciscus Wilhelmus Henricus Maria Merkus | A testosterone liquid spray formulation for oromucosal administration |
US9642862B2 (en) | 2010-11-18 | 2017-05-09 | White Mountain Pharma, Inc. | Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein |
AU2012256501B2 (en) | 2011-05-13 | 2017-04-06 | Eb Ip Hybritabs B.V. | Drug delivery system |
US9855281B2 (en) * | 2013-11-20 | 2018-01-02 | Scott Freeman Consultant, Llc | Libido-enhancing therapeutic and use |
US11439668B2 (en) | 2014-05-23 | 2022-09-13 | JangoBio, LLC | Methods to differentiate stem cells into hormone-producing cells |
US11253549B2 (en) * | 2014-05-23 | 2022-02-22 | JangoBio, LLC | Methods to rebalance the hypothalamic-pituitary-gonadal axis |
US20180207177A1 (en) * | 2017-01-23 | 2018-07-26 | Government Of The United States As Represented By The Secretary Of The Air Force | TREATMENT OF TRIPLE NEGATIVE BREAST CANCER UTILIZING ANDROST-5-ENE-3b,17b-DIOL (b-AED), ANDROST-5-ENE-3b,7b,17b-TRIOL (b-AET) AND ESTRADIOL (E2) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8301550A (nl) * | 1983-05-03 | 1984-12-03 | Gist Brocades Nv | Imidazolethanol esters. |
US5059603A (en) * | 1989-06-12 | 1991-10-22 | Centuries Laboratories, Inc. | Method and composition for treating impotence |
US5152997A (en) * | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
US5639743A (en) * | 1992-11-13 | 1997-06-17 | University Of Georgia Research Foundation | Compositions and methods for treating exocrine gland atrophy |
DE19619045C1 (de) * | 1996-05-02 | 1997-11-13 | Jenapharm Gmbh | Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen |
IT1283102B1 (it) * | 1996-06-06 | 1998-04-07 | Permatec Nv | Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele |
US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
ES2423899T3 (es) * | 2000-08-30 | 2013-09-25 | Unimed Pharmaceuticals, Llc | Método para aumentar las concentraciones de testosterona y esteroides relacionados en las mujeres |
-
2001
- 2001-06-27 US US09/892,981 patent/US20030027804A1/en not_active Abandoned
-
2002
- 2002-06-26 JP JP2003508362A patent/JP2005515964A/ja active Pending
- 2002-06-26 WO PCT/US2002/020141 patent/WO2003002123A2/en active Application Filing
- 2002-06-26 CA CA002451725A patent/CA2451725C/en not_active Expired - Lifetime
- 2002-06-26 EP EP02746682A patent/EP1404343A4/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005515964A5 (ja) | ||
RU2404750C2 (ru) | Композиция, содержащая основу или покрытие для замедленного высвобождения и антагонист nmda рецептора, способ введения такого nmda антагониста субъекту | |
JP2023002662A5 (ja) | ||
US8512751B2 (en) | Pharmaceutical compositions for sleep disorders | |
JP2005537268A5 (ja) | ||
HRP20161233T1 (hr) | Neurozaštita u demijelinizirajućim bolestima | |
HRP20220902T3 (hr) | Pripravci i njihova upotreba u liječenju multiple skleroze | |
AR075735A1 (es) | Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso | |
JP2005509662A5 (ja) | ||
JP2002532392A5 (ja) | ||
CN101073563B (zh) | 一种含有右旋布洛芬和左旋西替利嗪的手性组合物及其缓速释双层片 | |
JP2005515966A5 (ja) | ||
JP2009525343A5 (ja) | ||
JP2006503850A5 (ja) | ||
JP2013507415A5 (ja) | ||
JP2015524444A5 (ja) | ||
JP2009502951A5 (ja) | ||
JP2019515884A5 (ja) | ||
JP2008534592A5 (ja) | ||
JP2019515908A5 (ja) | ||
RS54050B1 (en) | FORMULATIONS AND METHODS FOR THE TREATMENT OF AMYLOIDOSIS | |
JP2005528430A5 (ja) | ||
RU2018146504A (ru) | Лечение внутрипеченочных холестатических заболеваний | |
JP2019507786A5 (ja) | ||
JP2002534477A5 (ja) |